Adaptive Biotechnologies (ADPT) EBITDA Margin Growth (3y) (2021 - 2026)
Adaptive Biotechnologies (ADPT) EBITDA Margin Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 263.00 |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | -168.00 |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 3,294.00 |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -56.00 |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -247.00 |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 360.00 |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 2,862.00 |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 146.00 |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 333.00 |
| 10 | Adaptive Biotechnologies | 4.23 Bn | 3.89 Bn | 51.39 Mn | 30,029.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30,029.00 |
| Mar 31, 2026 | 11,567.00 |
| Dec 31, 2025 | 8,283.00 |
| Sep 30, 2025 | 12,762.00 |
| Jun 30, 2025 | 10,994.00 |
| Mar 31, 2025 | 14,573.00 |
| Dec 31, 2024 | 13,754.00 |
| Sep 30, 2024 | 11,831.00 |
| Jun 30, 2024 | 8,682.00 |
| Mar 31, 2024 | 4,008.00 |
| Dec 31, 2023 | 12,481.00 |
| Sep 30, 2023 | 6,221.00 |
| Jun 30, 2023 | -14,647.00 |
| Mar 31, 2023 | 6,702.00 |
| Dec 31, 2022 | 2,892.00 |
| Sep 30, 2022 | -2,570.00 |
| Jun 30, 2022 | -4,750.00 |
| Mar 31, 2022 | -504.00 |
| Dec 31, 2021 | -8,012.00 |
| Sep 30, 2021 | -8,942.00 |